DEFINITIVE project: a clinical trial funded by the European Commission to demonstrate making personalized treatment decisions in early-stage HER2+ breast cancer
💡New blog post‼️ https://t.co/8FxgXM0qKw
HER2+ #BreastCancer is an aggressive type, but thanks to targeted therapies, outcomes have significantly improved. Let’s dive into the latest treatment strategies. 🧵⬇️
💡New blog post‼️ https://t.co/8FxgXM0qKw
HER2+ #BreastCancer is an aggressive type, but thanks to targeted therapies, outcomes have significantly improved. Let’s dive into the latest treatment strategies. 🧵⬇️
Backed by the @EU_Commission, the @DefinitiveTrial will validate #HER2DX's ability to improve treatment outcomes and reduce costs, potentially changing how we approach breast cancer care.